Wutah dodolan YoY sajrone 12 wulan kepungkur: MAIA Biotechnology (MAIA)

Logo perusahaan publik MAIA Bio (MAIA)

MAIA Biotechnology is optimizing biomaterial supplies for the development of immuno-oncology agents to maintain margins. The trailing four-quarter annual revenue growth rate confirms the trend, with the figure settling at 0.00. The company is integrating AI into drug synthesis, although medical decisions remain with physicians. Currently, the firm is developing targeted telomere activation methods to combat aggressive lung cancer.

Wutah pendapatan YoY sajrone 12 wulan kepungkur MAIA Biotechnology, Inc. (MAIA): kanggo periode 11.02.2024 - 16.11.2026

MAIA Biotechnology, Inc. (MAIA) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:MAIA Biotechnology
Sampel barang MAIABiotech.com

This indicator measures commercial revenue dynamics over a rolling year, neutralizing quarterly reporting gaps. By analyzing comparable year-over-year sales growth over 12 months on GURU.Markets, an investor assesses the fundamental scale of the business. The metric captures the percentage change in revenue, determining the stability of cash flows. For MAIA Biotechnology (MAIA), these levels depend on the efficiency of collaboration with external research centers. Controlling outsourcing costs directly impacts the final financial performance.

Pesaing MAIA Biotechnology (MAIA)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur REPL|lyell.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Innate Pharma S.A|Pyxis (PYXS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Compugen Ltd - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|IOBT (iobiotech.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) Sutro Biopharma Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur MiNK Therapeutics (INKT)|HOWL: Wutah dodolan taun lumaku|Immix Biopharma - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ALX Oncology (ALXO) - Wutah pendapatan taun lumaku|CUE: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku PDSB|sonnetbio.com (SONN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|LIMN - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur LVTX|Wutah dodolan YoY sajrone 12 wulan kepungkur NXTC (NextCure)|Wutah dodolan YoY sajrone rolas wulan kepungkur leaptx.com (LPTX)|INTS - Wutah pendapatan taun lumaku|Wutah dodolan YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur